|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Sage Therapeutics, Inc. (SAGE) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
58,290,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sage Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines with the potential to transform the lives of people with debilitating disorders of the brain. Co.'s principal product, ZULRESSO, is a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. Co.'s other product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder, and PPD. Co. has a portfolio of other compounds that target GABAA receptors, including SAGE-324. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
3,000 |
25,500 |
| Total Buy Value |
$0 |
$0 |
$87,779 |
$839,364 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
2 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
11,643 |
| Total Sell Value |
$0 |
$0 |
$0 |
$519,413 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jonas Jeffrey M |
President & CEO |
• • – |
2019-05-24 |
4 |
OE |
$0.45 |
$18,160 |
D/D |
40,356 |
102,471 |
|
- |
|
| Jonas Jeffrey M |
President & CEO |
• • – |
2019-05-23 |
4 |
AS |
$171.01 |
$9,407,253 |
D/D |
(53,908) |
62,115 |
|
- |
|
| Jonas Jeffrey M |
President & CEO |
• • – |
2019-05-23 |
4 |
OE |
$0.45 |
$24,259 |
D/D |
53,908 |
116,023 |
|
- |
|
| Cloonan Michael |
Chief Business Officer |
• – – |
2019-05-22 |
4 |
AS |
$175.00 |
$4,375,000 |
D/D |
(25,000) |
461 |
|
- |
|
| Cloonan Michael |
Chief Business Officer |
• – – |
2019-05-22 |
4 |
OE |
$73.43 |
$1,835,750 |
D/D |
25,000 |
25,461 |
|
- |
|
| Cook Anne Marie |
SVP, GC & Secretary |
• – – |
2019-05-10 |
4 |
OE |
$28.63 |
$468,839 |
D/D |
15,700 |
700 |
|
- |
|
| Cook Anne Marie |
SVP, GC & Secretary |
• – – |
2019-05-10 |
4 |
AS |
$166.14 |
$2,492,100 |
D/D |
(15,000) |
0 |
|
- |
|
| Frates James M |
|
– • – |
2019-05-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,700 |
2,535 |
|
- |
|
| Frates James M |
|
– • – |
2019-05-06 |
4 |
AS |
$162.22 |
$1,297,760 |
D/D |
(8,000) |
4,235 |
|
- |
|
| Frates James M |
|
– • – |
2019-05-06 |
4 |
OE |
$8.92 |
$71,360 |
D/D |
8,000 |
12,235 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-03-21 |
4 |
AS |
$161.02 |
$1,268,824 |
I/I |
(7,879) |
122,400 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-03-20 |
4 |
AS |
$161.20 |
$9,136,582 |
I/I |
(56,646) |
130,279 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-03-18 |
4 |
AS |
$161.01 |
$607,977 |
I/I |
(3,775) |
186,925 |
|
- |
|
| Iguchi Kimi |
CFO & Treasurer |
• – – |
2019-03-08 |
4 |
OE |
$0.45 |
$2,125 |
D/D |
4,723 |
6,136 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-03-01 |
4 |
AS |
$161.00 |
$418,600 |
I/I |
(2,600) |
190,700 |
|
- |
|
| Iguchi Kimi |
CFO & Treasurer |
• – – |
2019-03-01 |
4 |
AS |
$156.93 |
$4,011,602 |
D/D |
(25,563) |
1,413 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
122,400 |
193,300 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
122,400 |
119,295 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-25 |
4 |
AS |
$161.00 |
$322,000 |
I/I |
(2,000) |
70,900 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-19 |
4 |
AS |
$161.37 |
$249,373 |
I/I |
(1,543) |
72,900 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-15 |
4 |
AS |
$161.02 |
$7,964,210 |
I/I |
(49,461) |
74,443 |
|
- |
|
| Starr Kevin P |
Director |
– • – |
2019-02-12 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
0 |
|
- |
|
| Kanes Stephen |
Chief Medical Officer |
• – – |
2019-02-08 |
4 |
AS |
$150.00 |
$3,442,200 |
D/D |
(22,948) |
941 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
241,695 |
241,695 |
|
- |
|
| Paul Steven M |
|
– • – |
2019-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
241,695 |
272,777 |
|
- |
|
261 Records found
|
|
Page 5 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
